Cowen started coverage on shares of Curaleaf (OTCMKTS:CURLF) in a research report released on Friday, The Fly reports. The firm issued an outperform rating and a $11.00 price target on the stock.
Separately, Compass Point began coverage on shares of Curaleaf in a research report on Monday, June 10th. They set a buy rating on the stock.
Shares of Curaleaf stock opened at $7.55 on Friday. The company’s 50 day moving average is $7.21 and its 200 day moving average is $8.18. Curaleaf has a twelve month low of $3.88 and a twelve month high of $11.73.
Curaleaf Holdings, Inc operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles.
Recommended Story: Limitations of analyzing profit margin
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.